• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Liver Cancer UK HomepageLiver Cancer UK

Part of the British Liver Trust

  • About us
  • Health professionals
  • Talk to a nurse 0800 652 7330
  • Twitter
  • Liver cancer information
    • Types of liver cancer
      • HCC liver cancer
        • Overview
        • What is HCC?
        • Symptoms
        • Risks and causes
        • Diagnosis
          • Tests
          • Questions for your doctor
        • Treatment
          • Stages
          • Early stage HCC (0-A)
          • Intermediate HCC (stage B)
          • Advanced HCC (stage C)
          • Very advanced (stage D)
          • If your HCC comes back (recurrence)
          • Check-ups
          • Outcomes (prognosis)
        • Living with HCC
      • Bile duct cancer
        • Overview
        • What is bile duct cancer?
        • Symptoms
        • Risks and causes
        • Diagnosis
          • Tests
          • Questions for your doctor
        • Treatment
          • Stages
          • If cancer can be removed
          • If cancer can’t be removed
          • If cancer is advanced or has come back
          • Questions for your doctor
          • Check-ups
          • Outcomes (prognosis)
        • Living with bile duct cancer
      • Rare types of liver cancers
      • Secondary liver cancer
    • Just diagnosed?
    • Types of treatment
      • Surgery
        • Types of surgery
        • Preparing for surgery
        • After surgery
      • Targeted cancer medicines (biological therapies)
      • Chemotherapy
      • Embolization, TACE and TARE or SIRT
      • Ablation
      • Radiotherapy
      • Treatment for symptoms and advanced cancer
      • About clinical trials
    • Risk and causes of liver cancer
    • Liver cancer tests
    • Living with liver cancer
      • Diet and exercise
      • Coping with advanced cancer
      • Mental wellbeing
      • Money matters
      • Support from others
      • Complementary and alternative therapies
      • Patient stories
    • Our booklets and resources
    • Glossary / useful words
  • Support for you
  • How you can help
  • News and blogs
  • Donate
Home » News and Blogs » British Liver Trust joins over 50 cancer charities…
News

British Liver Trust joins over 50 cancer charities to call on the Government to ensure better cancer care

March 30, 2022

The British Liver Trust has worked with over 50 other charities, including Cancer Research UK, Macamillan and the Less Survivable Cancer Taskforce to submit a consensus statement on the Government’s Call for Evidence to inform a new 10-year Cancer Plan.

Drawing on our collective experiences from supporting people living with cancer, research, data and insight, we have developed this consensus statement, setting out what actions Government and the NHS need to take to ensure people diagnosed with cancer in England get the very best care and treatment.

If the new 10-year Cancer Plan is to be successful in delivering world leading and transformative change then we believe it must meet the following 10 tests:

  1. The 10-year Cancer Plan has clear political leadership, is fully costed and funded throughout its lifetime, with an annual report published on progress made against its ambitions.
  2. More cancers are prevented and England is ‘smoke free’ by 2030
  3. The public is aware of the risk factors, signs and symptoms of cancer and act on them, leading to improvements in presentation. Emergency presentation is reduced to no more than 5%.
  4. Progress towards early diagnosis is accelerated so that 78% of people are diagnosed at stage one or stage two and a 95% Faster Diagnosis Standard is met.
  5. Every person with cancer can access the treatment they need, at the right time, for the best outcomes. Cancer Waiting Time targets are met in every part of the country.
  6. By 2032, everyone with cancer is able to access a needs assessment and personalised care plan to support their health and wider wellbeing needs.
  7. Workforce and equipment shortages are addressed so that every person with cancer has access to the specialist workforce they need when they need it.
  8. Cases of cancer attributable to inequalities have meaningfully decreased.
  9. Clinical research capacity is increased, health service staff have access to dedicated research time and training and all populations are given the opportunity to participate in clinical trials.
  10. Data collection is timely, accessible, standardised and comprehensive and it is analysed and published swiftly to support the delivery and monitoring of all aspects of cancer across the pathway and cancer research.

These tests are elaborated on in the full consensus statement, which can be read here.

More news items
« Cancer survival gap still deadly
British Liver Trusts calls for action on liver cancer »

Footer

Liver Cancer UK logo
British Liver Trust logo

Quick links


  • Just been diagnosed
  • Living with cancer
  • Hepatocellular carcinoma (HCC)
  • Bile duct cancer

Contact us


Talk to a nurse on our helpline

0800 652 7330

General enquiries:

info@britishlivertrust.org.uk

01425 481 320

© British Liver Trust. All rights reserved. Registered Office: Venta Court, 20 Jewry Street, Winchester, SO23 8FE.
Registered Charity England and Wales 298858, Scotland SC042140. Company Limited by Guarantee Registered in England and Wales, Company No 2227706

Privacy policy | Cookies

Talk to a nurse on our helpline

0800 652 7330

Scroll Up